JG
PACB icon

Joel Greenblatt’s Pacific Biosciences PACB Stock Holding History

Joel Greenblatt’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,763
Closed -$24K – 1802
2025
Q3 		$24K Sell
18,763
-16,908
-47% -$22.9K ﹤0.01% 1674
2025
Q2 		$44.2K Buy
+35,671
New +$41.2K ﹤0.01% 1648
2023
Q3 		– Sell
-85,599
Closed -$1.14M – 1391
2023
Q2 		$1.14M Buy
+85,599
New +$1.04M 0.02% 731
2023
Q1 		– Sell
-20,128
Closed -$165K – 1375
2022
Q4 		$165K Buy
+20,128
New +$173K ﹤0.01% 1147
2021
Q2 		– Sell
-7,633
Closed -$254K – 1085
2021
Q1 		$254K Buy
+7,633
New +$267K 0.01% 887

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Joel Greenblatt's PACB Position: Q4 2025 in Review

Joel Greenblatt sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 18,763 shares — an estimated $24K sold.

Joel Greenblatt first reported a position in PACB in Q1 2021 and held it in 5 quarters. The position peaked at $1.14M in Q2 2023. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • Joel Greenblatt reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
  • Joel Greenblatt sold 18,763 Pacific Biosciences shares in Q4 2025, an estimated $24K.
  • Joel Greenblatt first reported a position in Pacific Biosciences in Q1 2021 and held it in 5 quarters.
  • Joel Greenblatt's Pacific Biosciences position peaked at $1.14M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on Gotham Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.